£55.00

Effects of Purslane Ethanolic extract on doxorubicin-induced toxicity: Biochemical effects of Purslane Ethanolic extract on doxorubicin-induced toxicity in albino rats

Price data last checked 86 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 5 days • 5 data points (No recent data available)

Historical
Generating forecast...
£55.00 £52.25 £53.35 £54.45 £55.55 £56.65 £57.75 05 February 2026 06 February 2026 07 February 2026 08 February 2026 09 February 2026

Price Distribution

Price distribution over 5 days • 1 price levels

Days at Price
5 days 0 1 3 4 5 £55 Days at Price

Price Analysis

Most common price: £55 (5 days, 100.0%)

Price range: £55 - £55

Price levels: 1 different prices over 5 days

Description

Doxorubicin (DOX), an anthracycline antibiotic, is a broad-spectrum antineoplastic agent, which is commonly used in the treatment of uterine, ovarian, breast and lung cancers, Hodgkin's disease and soft tissue sarcomas as well as in several other cancer types. The effect of doxorubicin intraperitoneal injection at dose level of 4 mg/kg b.w./week without or with oral administration of ethanolic purslane (Portulaca oleracea) shoot (leaves and stems) extract (50 mg/kg b.w./ day) or seed extract (50 mg/kg b.w.day) for 6 weeks was evaluated in adult male rats.

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
12 December 2016
Listed Since
12 April 2016

Barcode

No barcode data available

Similar Products You Might Like

DOXORUBICIN BIOSYNTHESIS CLINICAL US: Biosynthesis, Clinical Uses & Health Implications (Cancer Etiology, Diagnosis and Treatments)
94% match

DOXORUBICIN BIOSYNTHESIS CLINICAL US: Biosynthesis, Clinical Uses & Health Implications (Cancer Etiology, Diagnosis and Treatments)

£86.91 09 Mar 2026
Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3
93% match

Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3

Springer

£112.27 25 Jan 2026
Anticancer Agents from Natural Products
93% match

Anticancer Agents from Natural Products

CRC Press

£45.99 17 Mar 2026
Anticancer Agents from Natural Products
93% match

Anticancer Agents from Natural Products

CRC Press

£175.74 09 Jan 2026
Cardiotoxicity of Chemotherapeutic Agents (Cancer Etiology, Diagnosis and Treatments: Cardiology Research and Clinical Developments)
93% match

Cardiotoxicity of Chemotherapeutic Agents (Cancer Etiology, Diagnosis and Treatments: Cardiology Research and Clinical Developments)

£162.82 12 Jan 2026
Antitumoral Properties of Natural Products: Volume 2
93% match

Antitumoral Properties of Natural Products: Volume 2

MDPI AG

£54.50 04 Apr 2026
Antitumoral Properties of Natural Products
93% match

Antitumoral Properties of Natural Products

MDPI AG

£49.25 12 Feb 2026
Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)
93% match

Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)

Springer

£129.72 17 Mar 2026
Birkhauser Drugs Affecting Growth of Tumours - Medical Book
93% match

Birkhauser Drugs Affecting Growth of Tumours - Medical Book

Birkhauser

£56.68 04 Mar 2026
Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients, and Pharmacological Outcomes
93% match

Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients, and Pharmacological Outcomes

£129.48 04 Apr 2026
Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)
93% match

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Springer

£149.64 19 Apr 2026
Springer Anticancer Plants: Mechanisms and Molecular Interactions
93% match

Springer Anticancer Plants: Mechanisms and Molecular Interactions

Springer

£113.03 01 Mar 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
92% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£148.69 13 Jan 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
92% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£165.95 09 Apr 2026
Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development: Proceedings of the Twenty-Second Annual Cancer Symposium Detroit, ... 1990: 68 (Developments in Oncology, 68)
92% match

Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development: Proceedings of the Twenty-Second Annual Cancer Symposium Detroit, ... 1990: 68 (Developments in Oncology, 68)

Springer

£149.74 05 Apr 2026
The Chemistry of Antitumour Agents
92% match

The Chemistry of Antitumour Agents

Springer

£41.15 13 Apr 2026
Springer - Razoxane and Dexrazoxane: Experimental and Clinical
92% match

Springer - Razoxane and Dexrazoxane: Experimental and Clinical

Springer

£104.16 23 Feb 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
92% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£113.48 19 Apr 2026
Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)
92% match

Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)

Academic Press

£94.99 08 Apr 2026
Cancer Cell Chemoresistance And Chemosensitization
92% match

Cancer Cell Chemoresistance And Chemosensitization

Scientific Publishing

£148.00 11 Mar 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
92% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£87.47 24 Feb 2026
Cardiac Management of Oncology Patients: Clinical Handbook for Cardio-Oncology
92% match

Cardiac Management of Oncology Patients: Clinical Handbook for Cardio-Oncology

Springer

£39.18 12 Mar 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
92% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£75.84 01 Mar 2026
Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)
92% match

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

Springer

£83.59 25 Jan 2026